RecruitingNCT05340647

NorMIGS - a Study of Micro-invasive Glaucoma Surgery

NorMIGS - a Prospective Study of Micro-invasive Glaucoma Surgery


Sponsor

Oslo University Hospital

Enrollment

100 participants

Start Date

Apr 22, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data on patients with glaucoma who are undergoing minimally invasive glaucoma surgery (MIGS) — small procedures that lower eye pressure — to understand outcomes and how well different surgical devices work in a real-world Norwegian population. **You may be eligible if...** - You are 18 years or older - You are scheduled to receive a MIGS implant (such as a Preserflo microshunt or trabeculectomy) - You are able to cooperate with eye examinations - You are willing to participate and can give informed consent **You may NOT be eligible if...** - Your high eye pressure is caused by conditions like uveitis, blood in the eye (hemorrhagic glaucoma), trauma, or elevated vein pressure in the eye Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPreserflo microshunt

Implantation of Preserflo microshunt (Santen) to lower intraocular pressure

PROCEDURETrabeculectomy

Trabeculectomy surgery to lower intraocular pressure

PROCEDUREOther MIGS

Other MIGS than Preserflo microshunt (e.g., XEN gel stent, iStent inject) to lower intraocular pressure


Locations(1)

Department of Ophthalmology, Oslo University Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05340647


Related Trials